America’s decades-long war on smoking has been remarkably successful in reducing smoking rates, but the unintended consequences include stigmatizing people who smoke and people with lung cancer. Sadly, those dealing […] Read more
China’s Domestic PD-1/PD-L1 Inhibitors Demanding Global Attention
Leah LawrenceThe growth of these domestic drugs should shine a light on the lack of diversity in many international clinical trials in immunotherapy. Read more
Surgical Outcomes of CheckMate816 Support Use of Neoadjuvant Nivolumab Plus Chemotherapy for NSCLC
Leah LawrencePatients treated with neoadjuvant combination nivolumab plus chemotherapy who had resectable NSCLC underwent surgical resection at similar rates and timeframes to those undergoing neoadjuvant chemotherapy, according to a presentation of […] Read more
VIOLET Data Establishes VATS as Standard for Early-Stage Resectable NSCLC
Leah LawrenceA presentation of updated results from the VIOLET study comparing video-assisted thoracoscopic surgery (VATS) with open lobectomy showed that improvements in pain, in-hospital complications, and shorter hospital stay previously reported […] Read more
3D Model of Lung Nodules Reduces Anxiety for Patients While Helping Them Understand Their Cancer Risk
Beth Fand IncollingoThousands of Americans each year learn that CT chest screening has identified nodules on their lungs and, as a result, they often experience distress, fear, and confusion about their cancer […] Read more
July 1, 2021—The U.S. Food and Drug Administration (FDA) has approved FoundationOne CDx for use as a companion diagnostic for brigatinib, which the FDA had previously approved for treatment of […] Read more
High-Dose Once-Daily Thoracic Radiotherapy Did Not Improve OS in Limited Stage SCLC
Leah LawrenceHigh-dose 70 Gy once-daily thoracic radiotherapy did not significantly improve OS compared with the current standard of 45 Gy twice-daily radiotherapy in patients with limited-stage SCLC, according to results of […] Read more
Single Institution’s Experience: SABR Shows Outstanding OS vs. VATS in Patients with Early-Stage NSCLC
Leah LawrenceTreatment of operable, stage-I NSCLC with stereotactic ablative radiotherapy (SABR) was noninferior to video-assisted thoracic surgery (VATS) with mediastinal lymph node dissection (L-MLND). Joseph Y. Chang, MD, of The University […] Read more
Awareness-raising Bike Ride in The Netherlands Connected Hospitals, Patients
Ilima LoomisPatients and supporters cycled nearly 1,150 kilometers through The Netherlands on May 21, 2021 in a “White Ribbon Tour” to raise awareness for lung cancer. The grassroots event was organized […] Read more
Lung cancer is the leading cause of cancer mortality worldwide, with an estimated 2.1 million new cases and 1.8 million deaths in 2018—more than colon, breast, and prostate cancers combined.1 […] Read more